Clinical Trial Update: Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites [Phase 2]

View source ↗

Summary

Phase 2 trial update for continuous infusion terlipressin in patients with cirrhosis and refractory ascites has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Cirrhosis

Drugs mentioned

• Terlipressin (terlipressin)

Snippet

Sponsor: BioVie Inc. | Conditions: Cirrhosis, Ascites Hepatic | Phase 2 | Status: COMPLETED | Results posted: 2021-07-13